{
    "Trade/Device Name(s)": [
        "AllSource Drug Detector FenTest",
        "AllSource Drug Detector Fentanyl Test"
    ],
    "Submitter Information": "AllSource Screening Solutions",
    "510(k) Number": "K234006",
    "Predicate Device Reference 510(k) Number(s)": [
        "K233417"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGL"
    ],
    "Summary Letter Date": "February 9, 2024",
    "Summary Letter Received Date": "February 12, 2024",
    "Submission Date": "March 7, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Fentanyl"
    ],
    "Specimen Type(s)": [
        "Human Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Test Dip Card"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay",
        "Immunoassay"
    ],
    "Methodologies": [
        "Immunochemistry"
    ],
    "Submission Type(s)": [
        "Dip Card",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for AllSource Drug Detector FenTest and Fentanyl Test for qualitative detection of fentanyl in human urine using lateral flow immunochromatographic assay",
    "Indications for Use Summary": "Qualitative detection of fentanyl in human urine at a cutoff concentration of 1 ng/mL; provides preliminary test results and requires confirmatory testing by more specific methods such as GC/MS or LC/MS; for in vitro diagnostic use only",
    "fda_folder": "Toxicology"
}